During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed ...

A literature review from 2021 found that as many as 12% of people with an EGFR mutation have a type called the exon 20 insertion mutation. If you have EGFR-positive lung cancer, it means your EGFR ...

About 1% to 2% of NSCLCs have the ROS1 mutation. The ROS1 mutation is similar to the ALK mutation. Some of the same drugs help treat both mutations. Targeted therapies for ROS1-positive lung ...

We’ll primarily focus on the dose-expansion part. The phase 2 trial was focused on ROS1- positive NSCLC. There were also other cohorts for patients with nonlung cancer with ROS1 fusion. ROS1 can ...

Welcome to the NavRL repository! This repository provides the implementation of the NavRL framework, designed to enable robots to safely navigate dynamic environments using Reinforcement Learning.

Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML ...

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. However, ROS1-positive NSCLC affects only around 1-2% of people with NSCLC, which amounts to 18,500–37,000 new cases globally ...

Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants for the treatment of gastro-oesophageal reflux disease IPG222 27 June 2007 27 June 2007 Carmustine implants and ...

Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures CG64 17 March 2008 8 July 2016 ...